Sign in
4

Changes in Ownership

Foghorn Therapeutics Inc. Filed Acc 0001562180-21-004934

Options or other derivatives

  • Director acquired 12,530 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
KADOCH CIGALL Director 2021-07-13 Grant or award · Stock Option (right to buy) +12,530 12,530 D
Loading xslF345X03/primarydocument.xml…